Biographical Sketch
Arun D. Singh, MD, is Director of the Department of Ophthalmic Oncology in the Cole Eye Institute at Cleveland Clinic, Cleveland, Ohio. He is Fellow of the Royal College of Ophthalmologists, London, United Kingdom, and the American Board of Ophthalmology. He has published more than 160 scientific articles in peer-reviewed journals and has edited a major textbook, Clinical Ophthalmic Oncology, published by Elsevier. He is Editor of the British Journal of Ophthalmology.
Specialty Interests
eyelid and conjunctival tumors and von Hippel Lindau disease, retinoblastoma, Uveal Melanoma, Retinoblastoma
Awards & Honors
Achievement Award, American Academy of Ophthalmology
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 9/4/2008,
Dr. Singh has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
